approval
saveKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval
community read0 votes
Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
- approvalKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approvalFeb 10, 2026 · 236d ago
- approvalKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approvalNov 21, 2025 · 317d ago
- approvalKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approvalSep 19, 2025 · 380d ago
- approvalKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approvalSep 19, 2025 · 380d ago
same company · ±60 days · 4
- approvalpembrolizumab: KEYTRUDA (PEMBROLIZUMAB) — FDA approvalApr 6, 2026
- approvalsotatercept: WINREVAIR (SOTATERCEPT-CSRK) — FDA approvalMar 25, 2026
- approvalpembrolizumab: KEYTRUDA (PEMBROLIZUMAB) — FDA approvalFeb 10, 2026
- approval(berahyaluronidase alfa + pembrolizumab): KEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approvalFeb 10, 2026
comments(0)
5-min edit window · permanent after that